Search

Author/Creator Group, Thomas

1. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries. (June 2020)

Authors:
Kjaer, Susanne K.; Nygård, Mari; Sundström, Karin; Dillner, Joakim; Tryggvadottir, Laufey; Munk, Christian; Berger, Sophie; Enerly, Espen; Hortlund, Maria; Ágústsson, Ágúst Ingi; Bjelkenkrantz, Kaj; Fridrich, Katrin; Guðmundsdóttir, Ingibjorg; Sørbye, Sveinung Wergeland; Bautista, Oliver; Group, ...
Journal:
EClinicalMedicine
Issue:
Volume 23(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up. Issue 4 (3rd April 2021)

Authors:
Kjaer, Susanne K.; Nygård, Mari; Sundström, Karin; Munk, Christian; Berger, Sophie; Dzabic, Mensur; Fridrich, Katrin Elisabeth; Waldstrøm, Marianne; Sørbye, Sveinung Wergeland; Bautista, Oliver; Group, Thomas; Luxembourg, Alain
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 4(2021)
Page Start:
943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study. Issue 23 (20th May 2022)

Authors:
Lv, Huakun; Wang, Shenyu; Liang, Zhenzhen; Yu, Wei; Yan, Chuanfu; Chen, Yingping; Hu, Xiaosong; Fu, Rong; Zheng, Minghuan; Group, Thomas; Luxembourg, Alain; Liao, Xueyan; Chen, Zhiping
Journal:
Vaccine
Issue:
Volume 40:Issue 23(2022)
Page Start:
3263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Issue 3 (March 2022)

Authors:
Goldstone, Stephen E; Giuliano, Anna R; Palefsky, Joel M; Lazcano-Ponce, Eduardo; Penny, Mary E; Cabello, Robinson E; Moreira, Edson D; Baraldi, Ezio; Jessen, Heiko; Ferenczy, Alex; Kurman, Robert; Ronnett, Brigitte M; Stoler, Mark H; Bautista, Oliver; Das, Rituparna; Group, Thomas; Luxembourg, A...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 3(2022)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. Issue 6 (30th November 2022)

Authors:
Garland, Suzanne M.; Anagani, Manjula; Bhatla, Neerja; Chatterjee, Sukanta; Lalwani, Sanjay; Ross, Cecil; Group, Thomas; Lin, Jianxin; Luxembourg, Alain; Walia, Anuj; Tu, Yingmei
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study. Issue 4 (22nd January 2021)

Authors:
Huang, Zhuhang; He, Jianfeng; Su, Jiali; Ou, Zhiqiang; Liu, Guixiu; Fu, Rong; Shou, Qiong; Zheng, Minghuan; Group, Thomas; Luxembourg, Alain; Liao, Xueyan; Zhang, Jikai
Journal:
Vaccine
Issue:
Volume 39:Issue 4(2021)
Page Start:
760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years. Issue 5 (30th November 2022)

Authors:
Maldonado, Ivette; Plata, Manuel; Gonzalez, Mauricio; Correa, Alfonso; Nossa, Claudia; Giuliano, Anna R.; Joura, Elmar A.; Ferenczy, Alex; Ronnett, Brigitte M.; Stoler, Mark H.; Jin Zhou, Hao; Joshi, Amita; Das, Rituparna; Bautista, Oliver; Group, Thomas; Luxembourg, Alain; Saah, Alfred; Buchwald...
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 5(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial. Issue 7 (3rd July 2021)

Authors:
Thiem, Vu Dinh; Quang, Nguyen Dang; Tuan, Nguyen Hai; Cheon, Kyeongmi; Gallagher, Nancy; Luxembourg, Alain; Group, Thomas; Badshah, Cyrus
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 7(2021)
Page Start:
1980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗